Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinyu Bi

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Frontiers in Oncology|July 8, 2022
Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter StudyJiansheng Lin, Hongwei Zhang, Hongping Yu, et al.
Oncotarget|September 18, 2015
A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathwayHong Zhao, Yuming Guo, Shu Li, et al.
Science China. Life Sciences|March 22, 2022
Expert consensus on organizing the multidisciplinary team (MDT) diagnosis and treatment of hepato-pancreato-biliary diseases in ChinaBinhao Zhang, Jian Zhou, Weifen Xie, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 29, 2019
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAsYuechao Zhao, Yiran Li, Jie Sheng, et al.
Chinese Medical Journal|July 10, 2025
Diagnosis and treatment of colorectal liver metastases: Chinese expert consensus-based multidisciplinary team (2024 edition)Wen Zhang, Xinyu Bi, Yongkun Sun, et al.
Annals of Translational Medicine|April 3, 2023
Nomogram for tumour response based on prospective cohorts of hepatocellular carcinoma patients receiving immunotherapy combined with targeted therapy: development and validationQichen Chen, Yiqiao Deng, Chuanhua Zhao, et al.
International Journal of Surgery (London, England)|October 11, 2022
Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching studyQichen Chen, Rui Zhang, Baocai Xing, et al.
Medcomm|January 15, 2026
Landscape of Somatic and Age-Related Pathogenic Structural Variations in Hepatocellular Carcinoma Revealed by Long-Read SequencingZhewen Wei, Yinghao Cao, Hongchao Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 29, 2021
A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriersYuting Wang, Minjie Wang, He Li, et al.
Cancer Medicine|April 11, 2026
Efficacy and Safety of Intensity-Modulated Radiotherapy Combined With Regorafenib With or Without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Real-World Cohort Study From a Single CenterLingxia Xin, Zhiyu Li, Yirui Zhai, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Frontiers in Oncology|July 8, 2022
Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter StudyJiansheng Lin, Hongwei Zhang, Hongping Yu, et al.
Oncotarget|September 18, 2015
A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathwayHong Zhao, Yuming Guo, Shu Li, et al.
Science China. Life Sciences|March 22, 2022
Expert consensus on organizing the multidisciplinary team (MDT) diagnosis and treatment of hepato-pancreato-biliary diseases in ChinaBinhao Zhang, Jian Zhou, Weifen Xie, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 29, 2019
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAsYuechao Zhao, Yiran Li, Jie Sheng, et al.
Chinese Medical Journal|July 10, 2025
Diagnosis and treatment of colorectal liver metastases: Chinese expert consensus-based multidisciplinary team (2024 edition)Wen Zhang, Xinyu Bi, Yongkun Sun, et al.
Annals of Translational Medicine|April 3, 2023
Nomogram for tumour response based on prospective cohorts of hepatocellular carcinoma patients receiving immunotherapy combined with targeted therapy: development and validationQichen Chen, Yiqiao Deng, Chuanhua Zhao, et al.
International Journal of Surgery (London, England)|October 11, 2022
Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching studyQichen Chen, Rui Zhang, Baocai Xing, et al.
Medcomm|January 15, 2026
Landscape of Somatic and Age-Related Pathogenic Structural Variations in Hepatocellular Carcinoma Revealed by Long-Read SequencingZhewen Wei, Yinghao Cao, Hongchao Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 29, 2021
A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriersYuting Wang, Minjie Wang, He Li, et al.
Cancer Medicine|April 11, 2026
Efficacy and Safety of Intensity-Modulated Radiotherapy Combined With Regorafenib With or Without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Real-World Cohort Study From a Single CenterLingxia Xin, Zhiyu Li, Yirui Zhai, et al.
Pageof 14